Potential therapy of multidrug-resistant and extremely drug-resistant tuberculosis with thioridazine.
- Autores: Amaral L, Molnar J
- Ano de Publicação: 2012
- Journal: In vivo
- Link: http://www.ncbi.nlm.nih.gov/pubmed/22351663
Multidrug-resistant tuberculosis (MDRTB) infections that continue to increase in frequency globally have progressed to become extremely drug-resistant tuberculosis (XDRTB). The therapeutic problems associated with MDRTB pale in comparison to those for XDRTB where mortality is high.